M. Danese

B. Bradbury, G. Block, M. Danese, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Consistent control of mineral and bone disorder in incident hemodialysis patients.

K. Rothman, M. Danese, V. Belozeroff, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Treatment patterns and outcomes in older patients with advanced malignant pleural mesothelioma: Analyses of Surveillance, Epidemiology, and End Results‐Medicare data

D. Lubeck, J. Penrod, M. Gleeson, 2021, Cancer reports.

Abstract 18086: Rates of Cardiovascular Events in Patients Receiving High-Intensity Statin Therapy in the United Kingdom

K. Khunti, M. Lothgren, K. Ray, 2015, Circulation.

Short‐term and long‐term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: A systematic review

C. Kessler, K. Lindquist, M. Danese, 2009, American journal of hematology.

A novel approach to the evaluation of bleeding-related episodes in patients with chronic immune thrombocytopenia

B. Godeau, D. Henry, M. Gleeson, 2012, Current medical research and opinion.

Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.

A. Nissenson, B. Dean, R. Dubois, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Feasibility of Converting the Medicare Synthetic Public Use Data Into a Standardized Data Model for Clinical Research Informatics

Adler J. Perotte, Erica A. Voss, Amy Matcho, 2015, American Medical Informatics Association Annual Symposium.

Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United Kingdom.

M. Danese, P. Pemberton-Ross, D. Catterick, 2021, European journal of preventive cardiology.

An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer

C. O’Malley, K. Lindquist, M. Gleeson, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature.

N. Powe, C. Meinert, P. Ladenson, 2000, The Journal of clinical endocrinology and metabolism.

Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism.

G. Chertow, J. Cunningham, M. Danese, 2005, Kidney international.

When to treat mild hypothyroidism.

P. Ladenson, M. Danese, A. Ayala, 2000, Endocrinology and metabolism clinics of North America.

Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease

D. Lubeck, N. Bhakta, I. Agodoa, 2019, JAMA network open.

Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United Kingdom.

M. Danese, P. Pemberton-Ross, D. Catterick, 2020, European journal of preventive cardiology.

Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study

K. Khunti, K. Ray, M. Gleeson, 2017, BMJ Open.

Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context

J. Jansen, M. Danese, P. Toth, 2017, Journal of medical economics.

Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma.

M. Dreyling, M. Gleeson, M. Danese, 2011, Blood.

Hospitalizations in pediatric patients with immune thrombocytopenia in the United States

J. Bussel, R. Klaassen, M. Tarantino, 2016, Platelets.

Effect of Central Nervous System Metastases on Treatment Discontinuation and Survival in Older Women Receiving Trastuzumab for Metastatic Breast Cancer

K. Lindquist, M. Danese, R. Griffiths, 2012, Journal of cancer epidemiology.

Evaluation of Bleeding-Related Episodes in Patients with Chronic Immune Thrombocytopenia (ITP) Treated with Romiplostim in Two Phase 3 Placebo-Controlled Clinical Trials.

B. Godeau, D. Henry, M. Gleeson, 2009 .

Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer

A. O'Hagan, G. Lyman, J. Legg, 2012, PharmacoEconomics.

Catheter use is high even among hemodialysis patients with a fistula or graft.

A. Nissenson, R. Dubois, M. Danese, 2006, Kidney international.

Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States

A. Stopeck, David Henry, M. Danese, 2012, Journal of medical economics.

Impact of Hemodialysis Catheter Dysfunction on Dialysis and Other Medical Services: An Observational Cohort Study

G. Block, M. Danese, Britt B. Newsome, 2012, International journal of nephrology.

Treatment patterns, survival, and hospitalization in adult patients with acute lymphoblastic leukemia: an observational cohort study using SEER Medicare data

M. Kelsh, M. Gleeson, M. Danese, 2019, Leukemia & lymphoma.

Racial and Ethnic Variability in the Prevalence and Incidence of Comorbidities Associated with Gastric Cancer in the United States

M. Kelsh, Juan Ke, M. Gleeson, 2016, Journal of Gastrointestinal Cancer.

Estimated Cases of Blindness and Visual Impairment from Neovascular Age-Related Macular Degeneration Avoided in Australia by Ranibizumab Treatment

P. Mitchell, T. Wong, N. Bressler, 2014, PloS one.

Estimated Life-Years Saved in Women with HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States.

M. Danese, A. Masaquel, D. Lalla, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Second-line therapy in diffuse large B-cell lymphoma (DLBCL): treatment patterns and outcomes in older patients receiving outpatient chemotherapy

M. Dreyling, M. Gleeson, M. Danese, 2017, Leukemia & lymphoma.

Diabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema

N. Bressler, R. Varma, J. Ehrlich, 2020, Clinical ophthalmology.

Visual Impairment and Blindness Avoided with Ranibizumab in Hispanic and Non-Hispanic Whites with Diabetic Macular Edema in the United States.

Neil M Bressler, Rohit Varma, N. Bressler, 2015, Ophthalmology.

Validating the Follicular Lymphoma International Prognostic Index (FLIPI) Using SEER-Medicare Claims Data

K. Knopf, M. Gleeson, M. Danese, 2008 .

Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare

M. Gleeson, M. Danese, J. Mikhael, 2012, Journal of cancer epidemiology.

Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis

A. Collins, D. Gilbertson, B. Bradbury, 2016, BMC Nephrology.

Effect of Adherence on Lifetime Fractures in Osteoporotic Women Treated With Daily and Weekly Bisphosphonates

D. Bauer, E. Badamgarav, M. Danese, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Decision analysis in endocrinology and metabolism.

N. Powe, P. Ladenson, M. Danese, 1997, Endocrinology and metabolism clinics of North America.

Thyroid status, cardiovascular risk, and mortality in older adults.

L. Fried, L. Kuller, P. Ladenson, 2006, JAMA.

The Generalized Data Model for clinical research

Mark D. Danese, Jennifer Duryea, Ryan Duryea, 2017, bioRxiv.

PCN116 Cost-Effectiveness of Denosumab Versus Zoledronic Acid (ZA) for the Prevention of Skeletal-related Events (SRE) in Patients with Bone Metastases from Solid Tumors in the Netherlands

M. Lothgren, M. Danese, A. Bracco, 2011 .

Budget impact model of adding erlotinib to a regimen of gemcitabine for the treatment of locally advanced, nonresectable or metastatic pancreatic cancer.

D. Lubeck, C. Reyes, M. Danese, 2008, Clinical therapeutics.

Misclassification of incident conditions using claims data: impact of varying the period used to exclude pre-existing disease

C. O’Malley, M. Danese, R. Griffiths, 2013, BMC Medical Research Methodology.

Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care

J. Viallard, A. Giagounidis, R. Stasi, 2012, International Journal of Hematology.

Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare

J. Valderas, M. Gleeson, M. Danese, 2012, BMC Cancer.

Mortality differences among organisms causing septicemia in hemodialysis patients

A. Nissenson, R. Dubois, M. Danese, 2006, Hemodialysis international. International Symposium on Home Hemodialysis.

Comparative effectiveness and cost of adding rituximab to first‐line chemotherapy for elderly patients diagnosed with diffuse large B‐cell lymphoma

M. Dreyling, M. Gleeson, M. Danese, 2012, Cancer.

Avoiding Overestimation In Annualization of Event Risk from Risk Functions for use in Economic Modeling.

G Villa, M Lothgren, M Danese, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Impact of Undetected Comorbidity on Treatment and Outcomes of Breast Cancer

J. Valderas, M. Gleeson, M. Danese, 2014, International journal of breast cancer.

Systematic Literature Review of the Global Incidence and Prevalence of Myelodysplastic Syndrome and Acute Myeloid Leukemia

D. Lubeck, K. Miller, M. Danese, 2016 .

Prevalence and incidence of comorbidities in elderly women with ovarian cancer.

C. O’Malley, M. Kelsh, K. Lindquist, 2013, Gynecologic oncology.

Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients

D. Lubeck, M. Chonchol, M. Gleeson, 2020, American Journal of Nephrology.

Infused Therapy and Survival in Older Patients Diagnosed with Metastatic Breast Cancer who Received Trastuzumab

M. Danese, R. Griffiths, R. Herbert, 2011, Cancer investigation.

The association of vitamin D use with hypercalcemia and hyperphosphatemia in hemodialysis patients: a case–crossover study

K. Rothman, R. Kilpatrick, W. Goodman, 2011, Pharmacoepidemiology and drug safety.

Abnormal Bone and Mineral Metabolism in Kidney Transplant Patients – A Review

S. Sprague, M. Danese, V. Belozeroff, 2007, American Journal of Nephrology.

The prevalence, low-density lipoprotein cholesterol levels, and treatment of patients at very high risk of cardiovascular events in the United Kingdom: a cross-sectional study

M. Danese, L. Kutikova, E. Sidelnikov, 2018, Current medical research and opinion.

Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura

K. Lindquist, M. Gleeson, M. Danese, 2009, American journal of hematology.

Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998–2011

D. Lubeck, J. Grotta, M. Danese, 2016, International journal of stroke : official journal of the International Stroke Society.

A comparison of mixture cure fraction models to traditional parametric survival models in estimation of the cost-effectiveness of nivolumab for relapsed small cell lung cancer

S. Ramsey, J. Roth, M. Othus, 2020, Journal of medical economics.

CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis.

R. Kilpatrick, G. Block, M. Danese, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Undiagnosed Diabetes in Breast, Colorectal, Lung, and Prostate Cancer: Incidence and Risk Factors

J. Valderas, C. O’Malley, K. Lindquist, 2014, ISRN oncology.